COMPASSIONATE USE – Treating Physician AgreementCompassionate Use Agreement • August 29th, 2024
Contract Type FiledAugust 29th, 2024Pre-Approval Access/Compassionate Use of glofitamab for treatment of patients with relapsed/refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL), transformed Follicular Lymphoma (tFL) or Primary Mediastinal B-Cell Lymphoma (PMBCL) according to global Compassionate Use Program AG42296